CLERAMARC

Serial Number 87643499
606

Registration Progress

Application Filed
Oct 12, 2017
Under Examination
Apr 24, 2018
Approved for Publication
Feb 27, 2018
Published for Opposition
Feb 27, 2018
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: CLERAMARC
Previous Owner: Pfizer Inc
Classes: 005

Trademark Image

CLERAMARC

Basic Information

Serial Number
87643499
Filing Date
October 12, 2017
Published for Opposition
February 27, 2018
Abandonment Date
May 31, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 31, 2021
Classes
005

Rights Holder

Pfizer Inc

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc

Original Applicant
03
New York, NY

Pfizer Inc

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Heather McDonald

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

36 events
Date Code Type Description Documents
Jun 1, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 31, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 25, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 24, 2020 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 16, 2020 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 24, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 16, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 5, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 3, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 3, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 3, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 2, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 2, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 2, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 2, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 2, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 12, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 10, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 10, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 10, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 12, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 8, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 8, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 8, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 3, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 1, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 1, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 1, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 24, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 27, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 27, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 7, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 23, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 22, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 20, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 16, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005